German industry sets out nine-point innovation-led election message
This article was originally published in Clinica
BVMed, representing some 200 medical technology manufacturers in Germany, has become the latest healthcare association to release a position statement ahead of the September election. Last week, the hospital federation (DKG) made its voice heard on a range of subjects, including the need to promote high-quality patient care.
You may also be interested in...
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.